Clinical Trial Update: Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy of CL25216 for vasomotor symptoms in women during perimenopause is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• CL25216

Snippet

Sponsor: ApexCPG LLC | Conditions: Vasomotor Symptoms | NA | Status: RECRUITING